Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

NCT00190866 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00190866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Response Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2007
Enrollment
210
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia